A peer-reviewed article by researchers at the University of Shanghai for Science and Technology (USST), published in an international biomedical engineering journal, reports that the Hextra Tech™ ...

(n){if(!window.cnxel){window.cnxel={},window.cnxel.cmd=[];var t=n.createElement('iframe');t.src='javascript:false'; t.display='none',t.onload=function(){var ...

Key points A 40-year-old woman presented to her family physician with a new subcutaneous mass in the right lower quadrant of her abdomen, along with nonspecific systemic symptoms, including occasional ...

Gov. Gavin Newsom said Thursday that California will begin selling affordable insulin under its own label on Jan. 1, nearly three years after he first announced a partnership to sell state-branded ...

Abstract: Diabetes mellitus is a global health crisis characterized by poor blood sugar regulation, impacting millions of people worldwide and leading to severe complications and mortality. Although ...

Approximately 9.5 million people globally live with type 1 diabetes, a chronic autoimmune disease where T cells from the body's immune system destroy insulin-producing cells in the pancreas, which are ...

A used needle is seen on the ground on Friday, March 22, 2024, in Baker Park in Grants Pass, Ore. The two candidates vying to represent District 7 on Boston City Council have different opinions about ...

Boston City Councilors were divided on Wednesday over the hotly debated safe injection sites. One councilor introduced a resolution in opposition to them, which failed by an 8-3 vote. State lawmakers ...

The Boston City Council struck down a resolution opposing safe injection sites, with proponents rejecting notions that legalizing such centers would incentivize addicts to shoot up and saying that ...

A daily pill previously shown to slow the progression of type 1 diabetes has now shown a loss of therapeutic benefit when stopped—affirming the promise of the treatment. In 2023, an Australian trial ...